Medication info

Dongkuk Dapagliflozin Anhydrous Sugars Mixture Tablet 5 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Dapagliflozin Anhydrous Lactose Mixture›7.635mg / 1 tablet
Manufacturer / importer
Dongkuk Pharm Co., Ltd.
Appearance
Yellow, round, biconvex, film-coated tablets
Packaging
28 tablets/box [(7 tablets/PTP x 4)]
Approval status
Expired

MFDS item code 202005377 · Approved 2020.07.23

This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this drug is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Dongkuk Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used to assist in blood sugar control for patients with type 2 diabetes. It can be administered alone while following dietary and exercise therapies, and if sufficient blood sugar control is not achievable with monotherapy, it can be combined with other antidiabetic medications such as metformin, sulfonylureas, insulin, or sitagliptin. This helps achieve more effective blood sugar control. This medication is flexibly used according to various treatment situations and greatly aids in improving the patient's blood sugar management.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this drug is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients who have had allergic reactions to active ingredients or excipients. It may be dangerous to administer to patients with type 1 diabetes or diabetic ketoacidosis. This medication contains anhydrous lactose, so it should not be taken by patients with lactose intolerance or certain genetic metabolic disorders. It is also not to be used in patients undergoing dialysis. Caution should be exercised when administering to patients with insufficient fluid volume or reduced kidney function, as there is a risk of blood pressure reduction and kidney damage. Elderly patients or those taking diuretics are at higher risk of hypotension with this medication and require careful monitoring. If there is an allergy to the coloring agents included in this medication, it should be used with caution. The risk of genital infections and urinary tract infections may increase while taking this medication, so immediate treatment is necessary if symptoms occur. There is a risk of hypoglycemia; therefore, dose adjustments may be required when taken with insulin or sulfonylureas. If symptoms of reduced fluid volume occur, immediate consultation with a healthcare professional is advised, and medication should be temporarily discontinued if necessary. Serious metabolic anomalies such as diabetic ketoacidosis may occur, so if symptoms like vomiting, abdominal pain, or difficulty breathing arise, immediate hospital visit is necessary. Elderly patients or those with reduced kidney function should carefully monitor kidney function and blood pressure before and after taking this medication. It is safest to avoid taking this medication during pregnancy or while breastfeeding. In case of overdose, as there are no specific antidotes, appropriate treatment should be administered according to symptoms. This medication does not significantly affect driving or operating machinery, but precautions for the risk of hypoglycemia should be taken. When storing, keep it out of reach of children and store in its original container.

Side effects

  • Vulvovaginitis
  • balanitis
  • genital infections
  • urinary tract infections
  • fungal infections
  • perineal necrosis
  • hypoglycemia
  • decreased fluid volume
  • thirst
  • diabetic ketoacidosis
Show 93 more
  • dizziness
  • constipation
  • dry mouth
  • back pain
  • painful urination
  • polyuria
  • nocturia
  • interstitial nephritis
  • vulvar pruritus
  • genital pruritus
  • elevated hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • elevated serum creatinine
  • elevated blood urea
  • weight loss
  • rash
  • angioedema
  • urosepsis
  • pyelonephritis
  • acute kidney injury
  • renal dysfunction
  • gastroesophageal reflux disease
  • epigastric pain
  • diverticulosis
  • intestinal perforation
  • acute pancreatitis
  • chronic pancreatitis
  • hyperglycemia
  • paresthesia
  • cerebral infarction
  • nerve compression
  • sinusitis
  • diverticulitis
  • pelvic inflammatory disease
  • pneumonia
  • pulmonary tuberculosis
  • asthenia
  • pain
  • ligament sprain
  • road traffic accidents
  • drug overdose
  • ankle fracture
  • hand fracture
  • pelvic fracture
  • meniscal injury
  • thoracic spine fracture
  • tibial fracture
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina
  • myocardial infarction
  • bile duct stones
  • cholangitis
  • alcoholic cirrhosis
  • depression
  • suicide attempts
  • gastric adenocarcinoma
  • anaphylactic reaction
  • sensory impairment
  • headache
  • nasopharyngitis
  • upper respiratory infection
  • chest pain
  • fatigue
  • chest discomfort
  • peripheral edema
  • generalized edema
  • hunger
  • vaginal discharge
  • menstrual irregularities
  • pruritus
  • urticaria
  • cold sweat
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • ligament sprain
  • diabetic retinopathy
  • cough
  • dyspnea
  • orthostatic hypotension
  • palpitations
  • insomnia
  • fatty liver
  • gallbladder polyps
  • tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. The appropriate storage temperature is room temperature between 1 to 30 degrees Celsius, avoiding excessively hot or cold places.

Appearance and packaging

Appearance

Yellow, round, biconvex, film-coated tablets

Package unit

28 tablets/box [(7 tablets/PTP x 4)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.